Molecular and Cellular Biology of Human Oncogenic Viruses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 2073
Special Issue Editor
Special Issue Information
Dear Colleagues,
The number of oncovirus-associated cancers has been increasing in recent years; it has been estimated that approximately 10% of neoplastic diseases in the world correlate with viral infections. Therefore, understanding the molecular mechanisms through which oncoviruses regulate viral and host gene expression may help in identifying potential therapeutic targets. There are currently seven recognized viruses associated with human cancer, namely EBV, KSHV, HPV, HTLV-1, HBV, HCV, and MCV. They are able to infect different cell types and can adopt similar and specific strategies to trigger the transformation of their target cells.
The aim of this Special Issue is to provide new insights into the mechanisms underlying viral oncogenesis in the attempt to identify new drugs, enabling the manipulation of the viral lytic cycle, which, in some cases, can be latent or lytic, or target the epigenetic changes and the activation of pro-oncogenic molecular pathways that oncoviruses may induce. The study of mechanisms leading to the establishment of viral infections may also provide useful information on cancer prevention, including the development of vaccines against oncoviruses.
We are looking forward to receiving your contributions.
Dr. Roberta Gonnella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncoviruses
- antiviral drugs
- viral oncogenesis
- viral infection
- oncogenic pathways
- epigenetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
